VAERS reports by lot

GSK Varicella/Shingles lot 5H29X: VAERS reports

85 VAERS reports list lot 5H29X as a GSK Varicella/Shingles vaccine, received between 2022-05-17 and 2024-05-22. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
85
Reports
0%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2329%
General / Systemic (non-local)1317%
Dermatological (non-injection-site)1215%
Neurological912%
Allergic / Anaphylactic810%
Musculoskeletal79%
Cardiac / Cardiovascular34%
Thrombotic / Hematological11%
Respiratory11%
Gastrointestinal11%

Where reports came from

U.S. state of the reporter, where given (top 12).

District of Columbia47
Virginia4
Maryland4
New York4
Ohio3
Pennsylvania3
Arizona2
West Virginia1
Massachusetts1
Michigan1
North Carolina1
Indiana1

Reports by month received

2022-052
2022-0610
2022-075
2022-082
2022-092
2022-102
2022-111
2022-121
2023-032
2023-1211
2024-0114
2024-0218
2024-031
2024-048
2024-056

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.